Effect of 5-fluorouracil, optison and ultrasound on MCF-7 cell viability

被引:51
作者
Chumakova, OV
Liopo, AV
Evers, BM
Esenaliev, RO
机构
[1] Univ Texas, Med Branch, Sealy Ctr Canc Cell Biol, Ctr Biomed Engn, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Surg, Galveston, TX 77555 USA
[3] Univ Texas, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA
[4] Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA
关键词
MCF-7; cells; ultrasonication; 5-fluorouracil; optison;
D O I
10.1016/j.ultrasmedbio.2006.01.011
中图分类号
O42 [声学];
学科分类号
070206 [声学]; 082403 [水声工程];
摘要
The aim of this study was to analyze cell viability and expression of apoptotic-related signaling proteins in MCF-7 breast cancer cells induced by combinations of ultrasound, the anticancer drug 5-fluorouracil (5-FU) and the ultrasound contrast agent Optison. MCF-7 cells were treated with 5-FU and sonicated at the frequency of 3.0 MHz and intensity of 3.0 W/cm(2) for 1 min in the presence of Optison. The cells were analyzed for lactate dehydrogenase (LDH) release (a measure of cytotoxicity) and cell proliferation (by MTT assays). The LDH/MTT ratio was used for assessment of cell death. Expression of the apoptotic-related proteins, Bax and p27(kip1), as well as phosphorylated forms of ERK and Akt proteins was assessed by Western blot analysis. We demonstrate that, immediately after treatment, cell death was most dependent on Optison; however, 24 h after treatment, cell death was more dependent on 5-FU. Ultrasound duty cycle increased cell death associated with either Optison or 5-FU. Furthermore, we show that treatment with 5-FU and ultrasound increased the levels of the Bax and P27(kip1) proteins, but the addition of Optison appears to suppress apoptotic protein expression. (E-mail: rinat.esenaliev@utmb.edu) (c) 2006 World Federation for Ultrasound in Medicine & Biology.
引用
收藏
页码:751 / 758
页数:8
相关论文
共 30 条
[1]
Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells [J].
Antonsson, B ;
Montessuit, S ;
Sanchez, B ;
Martinou, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) :11615-11623
[2]
Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine [J].
Bekeredjian, R ;
Grayburn, PA ;
Shohet, RV .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) :329-335
[3]
Effects of ultrasound-targeted microbubble destruction on cardiac gene expression [J].
Bekeredjian, R ;
Chen, SY ;
Pan, WT ;
Grayburn, PA ;
Shohet, RV .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2004, 30 (04) :539-543
[4]
THE BINDING OF 5-FLUOROURACIL TO NATIVE AND MODIFIED HUMAN SERUM-ALBUMIN - UV, CD, AND H-1 AND F-19 NMR INVESTIGATION [J].
BERTUCCI, C ;
ASCOLI, G ;
UCCELLOBARRETTA, G ;
DIBARI, L ;
SALVADORI, P .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (09) :1087-1093
[5]
The differential effects of cyclophosphamide, epirubicin and 5-fluorouracil on apoptotic marker (CPP-32), pro-apoptotic protein (p21WAF-1) and anti-apoptotic protein (bcl-2) in breast cancer cells [J].
Chow, LWC ;
Loo, WTY .
BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (03) :239-244
[6]
Clinical studies of apoptosis and proliferation in breast cancer [J].
Dowsett, M ;
Archer, A ;
Assersohn, L ;
Gregory, RK ;
Ellis, PA ;
Salter, J ;
Chang, J ;
Mainwaring, P ;
Boeddinghaus, I ;
Johnston, SRD ;
Powles, TJ ;
Smith, IE .
ENDOCRINE-RELATED CANCER, 1999, 6 (01) :25-28
[7]
Enhancement of ultrasound-induced apoptosis and cell lysis by echo-contrast agents [J].
Feril, LB ;
Kondo, T ;
Zhao, QL ;
Ogawa, R ;
Tachibana, K ;
Kudo, N ;
Fujimoto, S ;
Nakamura, S .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2003, 29 (02) :331-337
[8]
MCF-7 growth inhibition by ultraviolet radiation and 5-fluorouracil: the importance of treatment sequence [J].
Hamaoka, T ;
Furuya, Y ;
Yamamoto, K ;
Kuroda, Y .
CANCER LETTERS, 2000, 154 (02) :183-187
[9]
Role of intracellular calcium ions and reactive oxygen species in apoptosis induced by ultrasound [J].
Honda, H ;
Kondo, T ;
Zhao, QL ;
Feril, LB ;
Kitagawa, H .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2004, 30 (05) :683-692
[10]
Kim R, 2004, INT J MOL MED, V14, P697